Ngā hua rapu - Robert Jenke

  • E whakaatu ana i te 1 - 3 hua o te 3
Whakamahine hua
  1. 1
    Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives

    Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives mā Robert Jenke, Nina Reßing, Finn K. Hansen, Achim Aigner, Thomas Büch

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer

    HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer mā Robert Jenke, Denys Oliinyk, Tamara Zenz, Justus Körfer, Linda Schäker‐Hübner, Finn K. Hansen, Florian Lordick, Florian Meier-Rosar, Achim Aigner, Thomas Büch

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors

    Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors mā Linda Schäker‐Hübner, Reza Haschemi, Thomas Büch, Fabian B. Kraft, Birke Brumme, Andrea Schöler, Robert Jenke, Jens Meiler, Achim Aigner, Gerd Bendas, Finn K. Hansen

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: